Quantum Genomics News Today

Press release - InsightAce Analytic Pvt.Ltd - Left Appendage Occlusion Device Market Closing the Gap on Stroke Risk: The Left Atrial Appendage Occlusion Device - published on openPR.com

The Quantum Genomics Company announces that, as part of its merger project with Exactcure, French HealthTech developing artificial intelligence software to adapt medication intake to the profile...

The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding...

/PRNewswire/ -- DelveInsights Drug-Eluting Balloons Market Insights report provides the current and forecast market analysis, individual leading drug-eluting...

/PRNewswire/ -- DelveInsights Heart Failure Market Insights report includes a comprehensive understanding of current treatment practices, heart failure...

ExactCure, a private French HealthTech company developing an innovative artificial intelligence device to tailor drug administration to each individual's profile A technology with CE...

After announcing on July 20, 2023, the signing of a letter of intent for a potential merger with Vistacare Medical, subject to satisfactory due diligence audits, Quantum Genomics today announces...

Quantum Genomics enters into exclusive negotiations with Vistacare Medical with the ambition of creating a reference player in the management of complex wounds A French HealthTech company...

/PRNewswire/ -- DelveInsights Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging...

Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on angiotensin-converting enzyme inhibitor